8-KLeadership Changes

STRYKER CORP 8-K Report, Executive Changes (Dec 10, 2004)

Filed December 10, 2004For Securities:SYK

Summary

Stryker Corporation (SYK) announced a significant leadership transition via an 8-K filing on December 10, 2004. Effective January 1, 2005, Stephen P. MacMillan will assume the roles of President and Chief Executive Officer. Mr. MacMillan, who joined Stryker in June 2003 as President and Chief Operating Officer, brings extensive experience from his previous roles at Pharmacia Corporation and Johnson & Johnson. This transition marks the retirement of current CEO John W. Brown from his executive duties, although he will remain as non-executive Chairman of the Board. Mr. MacMillan's appointment to CEO, coupled with his election to the Board of Directors, signals a continuation of Stryker's strategic direction under new leadership. Investors should view this as a planned succession, with Mr. MacMillan's prior experience suggesting a smooth handover and ongoing commitment to the company's growth objectives.

Key Highlights

  • 1Stephen P. MacMillan appointed President and Chief Executive Officer, effective January 1, 2005.
  • 2Stephen P. MacMillan also elected to the Board of Directors, effective January 1, 2005.
  • 3John W. Brown to retire as CEO but will continue as non-executive Chairman of the Board.
  • 4Mr. MacMillan joined Stryker in June 2003 as President and Chief Operating Officer.
  • 5Mr. MacMillan has a strong background with previous roles at Pharmacia Corporation and Johnson & Johnson.
  • 6This represents a planned leadership succession for Stryker Corporation.

Frequently Asked Questions

This 8-K filing announces a significant leadership change at Stryker Corporation. Specifically, it details the appointment of Stephen P. MacMillan as the new President and Chief Executive Officer, effective January 1, 2005, and the retirement of the current CEO, John W. Brown, from his executive role.

Stephen P. MacMillan, age 41, has been with Stryker since June 2003 as President and Chief Operating Officer. Prior to that, he held senior leadership positions at Pharmacia Corporation and spent 11 years at Johnson & Johnson. He has a Bachelor of Arts in Economics from Davidson College and is a graduate of the Harvard Business School Advanced Management Program.

John W. Brown, who is currently Chairman of the Board and CEO, will be retiring as Chief Executive Officer. However, he will continue to serve the company as the non-executive Chairman of the Board after January 1, 2005.

Mr. MacMillan's election to a newly-created position on the Board of Directors, effective January 1, 2005, alongside his appointment as CEO, indicates a formal integration of leadership and governance. It signifies his elevation to a key decision-making body within the company.